Digital therapeutics has caught the eye of pharmaceutical companies as a potential balm to a host of the pharma industry's struggles, according to MedCity News.
Digital therapeutics is a category of software — typically in the form of consumer-facing mobile health apps — that replaces or complements the existing treatment of a disease.